Naval Daver Selected Research

Hematologic Neoplasms (Hematological Malignancy)

1/2023	Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies.
1/2021	T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments.
1/2021	Immunotherapy in Acute Myeloid Leukemia: Where We Stand.
1/2018	Unmet clinical needs and economic burden of disease in the treatment landscape of acute myeloid leukemia.
1/2018	Immune therapies in acute myeloid leukemia: a focus on monoclonal antibodies and immune checkpoint inhibitors.
10/2017	Immunotherapy based approaches in myelofibrosis.
10/2016	Targeting Immune Checkpoints in Hematologic Malignancies.
4/2015	Myelopathy following intrathecal chemotherapy in adults: a single institution experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naval Daver Research Topics

Disease

135	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 04/2012
58	Neoplasms (Cancer) 05/2024 - 01/2013
38	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2024 - 03/2013
36	Leukemia 12/2023 - 06/2013
18	Primary Myelofibrosis (Myelosclerosis) 03/2024 - 01/2013
17	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2024 - 05/2015
17	Philadelphia Chromosome 06/2023 - 02/2015
16	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 06/2013
12	Infections 11/2023 - 11/2015
9	Residual Neoplasm 01/2021 - 06/2016
8	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 04/2015
7	Exanthema (Rash) 11/2023 - 11/2015
7	Acute Promyelocytic Leukemia 01/2022 - 05/2015
5	Blast Crisis (Blast Phase) 01/2023 - 12/2017
5	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023 - 04/2014
5	Anemia 01/2022 - 11/2013
5	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2018
4	Disease Progression 05/2024 - 01/2021
4	Splenomegaly 03/2024 - 10/2014
4	Hypertension (High Blood Pressure) 01/2023 - 11/2015
4	Chromosome Aberrations (Chromosome Abnormalities) 11/2022 - 01/2018
4	Bites and Stings (Sting) 01/2021 - 01/2017
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 01/2018
4	Pathologic Complete Response 01/2019 - 05/2015
3	Neutropenia 04/2024 - 02/2019
3	Nausea 11/2023 - 02/2015
3	Pneumonia (Pneumonitis) 01/2023 - 01/2020
3	Lymphoma (Lymphomas) 01/2022 - 05/2015
3	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2021 - 01/2017
3	Hemorrhage 12/2018 - 01/2015
3	Multiple Myeloma 10/2017 - 02/2015
2	Inflammation (Inflammations) 02/2024 - 09/2017
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 06/2013

Drug/Important Bio-Agent (IBA)

28	venetoclaxIBA 04/2024 - 01/2018
24	Azacitidine (5 Azacytidine)FDA Link 02/2024 - 06/2013
17	Immune Checkpoint InhibitorsIBA 01/2024 - 10/2016
17	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2023 - 11/2013
16	Tyrosine Kinase InhibitorsIBA 01/2022 - 02/2015
9	ruxolitinibIBA 03/2024 - 02/2015
9	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 11/2023 - 11/2013
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2017
9	Decitabine FDA Link 01/2022 - 02/2015
8	Sorafenib (BAY 43-9006)FDA Link 11/2023 - 06/2013
8	ponatinibIBA 01/2023 - 09/2015
8	NivolumabIBA 01/2023 - 01/2017
8	Core Binding Factors (Core-Binding Factor)IBA 01/2023 - 11/2015
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2018
7	Dasatinib (BMS 354825)FDA Link 04/2024 - 03/2016
7	AntibodiesIBA 01/2023 - 10/2016
6	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2024 - 08/2013
6	AntigensIBA 12/2023 - 05/2016
6	Chimeric Antigen ReceptorsIBA 01/2023 - 02/2017
6	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 02/2015
6	fms-Like Tyrosine Kinase 3IBA 01/2021 - 08/2012
5	CytokinesIBA 02/2024 - 01/2017
5	blinatumomabIBA 06/2023 - 12/2017
5	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 02/2017
5	Gemtuzumab (Mylotarg)FDA Link 11/2022 - 01/2017
5	Lenalidomide (CC 5013)FDA Link 10/2022 - 01/2015
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 05/2015
5	Monoclonal AntibodiesIBA 01/2021 - 06/2013
5	Clofarabine (Clolar)FDA Link 01/2021 - 06/2013
5	Arsenic Trioxide (Trisenox)FDA Link 01/2019 - 05/2015
4	Cladribine FDA LinkGeneric 11/2023 - 01/2014
4	BilirubinIBA 11/2023 - 02/2015
4	Inotuzumab OzogamicinIBA 06/2023 - 01/2018
4	CreatinineIBA 01/2022 - 12/2018
4	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 05/2015
4	DNA (Deoxyribonucleic Acid)IBA 07/2019 - 02/2015
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019 - 05/2015
3	Alanine Transaminase (SGPT)IBA 01/2023 - 11/2015
3	fludarabineIBA 01/2023 - 01/2018
3	EnzymesIBA 01/2023 - 01/2017
3	gilteritinibIBA 12/2022 - 12/2021
3	AnthracyclinesIBA 05/2022 - 01/2020
3	Immunoconjugates (Immunoconjugate)IBA 01/2021 - 01/2017
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 02/2015
3	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2021 - 01/2013
3	SteroidsIBA 01/2021 - 06/2017
3	midostaurinIBA 11/2019 - 04/2015
3	Transaminases (Aminotransferases)IBA 12/2018 - 02/2015
3	Prednisone (Sone)FDA LinkGeneric 12/2018 - 09/2014
3	pomalidomideIBA 10/2017 - 11/2013
3	Methotrexate (Mexate)FDA LinkGeneric 02/2017 - 02/2015
3	Hemoglobins (Hemoglobin)IBA 01/2017 - 09/2014
3	Rituximab (Mabthera)FDA Link 02/2015 - 02/2013
2	PLX51107IBA 11/2023 - 01/2022
2	Bispecific AntibodiesIBA 01/2023 - 01/2018
2	IACS-010759IBA 01/2023 - 01/2018
2	ibrutinibIBA 01/2023 - 05/2015
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 11/2015

Therapy/Procedure

100	Therapeutics 03/2024 - 01/2013
48	Drug Therapy (Chemotherapy) 05/2024 - 08/2013
14	Stem Cell Transplantation 12/2023 - 03/2013
11	Immunotherapy 05/2024 - 06/2013
8	Induction Chemotherapy 01/2022 - 08/2012
5	Hematopoietic Stem Cell Transplantation 01/2023 - 03/2013
3	Radiotherapy 10/2022 - 10/2014
3	Transplantation 01/2021 - 12/2019
3	Salvage Therapy 01/2021 - 01/2020